Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Founded Date:
2010-01-01
Total Funding:
35017490
Employee Number:
9
Funding Status:
Early Stage Venture
Number Of Exists:
11-50
Last Funding Type:
Series B
Investors Number:
6
Last Funding Date:
2021-12-16
Industry:
Aging Biomarkers
Headquarters:
Oxford, Oxfordshire, United Kingdom
Estimated Revenue:
$33.16M